SLXN - Silexion Therapeutics Corp. Quick Ratio

The share price history of Silexion Therapeutics Corp (SLXN) on the GURU.Markets platform, where the current figure stands at 0.97, reflects the dynamics of a business implementing CRISPR robots for accelerated RNA drug selection. Its proprietary high-tech infrastructure protects the company from the pricing pressure of traditional medications. Financial success is driven by clinic demand within the solid tumor therapy segment and the fight against the KRAS mutation in pancreatic cancer.

Quick liquidity reflects the ability of a company to instantaneously settle short-term debts without liquidating inventory. This quick liquidity trend on the chart demonstrates the balance between available cash flow and debt load. The formula excludes illiquid assets, revealing the enterprise's real financial stability before creditors. For Silexion Therapeutics Corp (SLXN), this reserve is critically important, as the advance trust of funds requires stable financing for oncology research.